Paper782834
Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.
Pinder RM and 4 others. Drugs, 1976. Cited by 88 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism. Papers, record 782834. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/782834
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Benserazide | Major topic |
| Carbidopa | Major topic |
| Carboxy-Lyases | Major topic |
| Hydrazines | Major topic |
| Levodopa | Major topic |
| Parkinson Disease | Major topic |
| Binding Sites | |
| Drug Interactions | |
| Humans | |
| Kinetics | |
| Liver Function Tests |
Source PubMed
References107
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,691,682 | Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylase. | J Neurol Neurosurg Psychiatry | 1973 | https://conductscience.org/library/papers/4691682 | PubMed |
| 2 | 4,217,929 | [Results after 3 to 5 years of treatment of 219 cases of Parkinson's syndrome treated by L-Dopa and an L-Dopa -decarboxylase inhibitor combination]. | Rev Neurol (Paris) | 1974 | https://conductscience.org/library/papers/4217929 | PubMed |
| 3 | 4,750,934 | [Therapy of parkinsonism using a combination of L-dopa and decarboxylase inhibitor]. | Med Welt | 1973 | https://conductscience.org/library/papers/4750934 | PubMed |
| 4 | 5,115,985 | [Clinical studies on the treatment of parkinsonism with the L-dopa and decarboxylase inhibitor Ro-4-4602 association]. | Wien Med Wochenschr | 1971 | https://conductscience.org/library/papers/5115985 | PubMed |
| 5 | 4,114,458 | Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor. | Z Neurol | 1972 | https://conductscience.org/library/papers/4114458 | PubMed |
| 6 | 4,695,662 | [Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease]. | Arch Psychiatr Nervenkr (1970) | 1973 | https://conductscience.org/library/papers/4695662 | PubMed |
| 7 | 4,769,026 | [Combination of L-dopa, desipramine, and a decarboxylase inhibitor in the treatment of depression (author's transl)]. | Psychopharmacologia | 1973 | https://conductscience.org/library/papers/4769026 | PubMed |
| 8 | 4,155,220 | Abnormal involuntary movements induced by anticholinergic therapy. | Acta Neurol Scand | 1974 | https://conductscience.org/library/papers/4155220 | PubMed |
| 9 | 4,275,492 | [2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)]. | Wien Med Wochenschr | 1974 | https://conductscience.org/library/papers/4275492 | PubMed |
| 10 | 5,577,486 | Cardiovascular effects of levodopa. | Clin Pharmacol Ther | 1971 | https://conductscience.org/library/papers/5577486 | PubMed |
| 11 | 1,107,835 | Treatment of Parkinson's disease with aporphines. Possible role of growth hormone. | N Engl J Med | 1976 | https://conductscience.org/library/papers/1107835 | PubMed |
| 12 | 5,026,378 | Levodopa and pressor amine sensitivity in parkinsonism. | Clin Pharmacol Ther | 1972 | https://conductscience.org/library/papers/5026378 | PubMed |
| 13 | 4,698,567 | Potentiation of levodopa stimulation of human growth hormone by systemic decarboxylase inhibition. | Clin Pharmacol Ther | 1973 | https://conductscience.org/library/papers/4698567 | PubMed |
| 14 | 5,067,774 | Melatonin and parkinsonism. | JAMA | 1972 | https://conductscience.org/library/papers/5067774 | PubMed |
| 15 | 4,197,759 | [Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor]. | Munch Med Wochenschr | 1973 | https://conductscience.org/library/papers/4197759 | PubMed |
| 16 | 4,143,315 | Treatment of parkinsonism with bromocriptine. | Lancet | 1974 | https://conductscience.org/library/papers/4143315 | PubMed |
| 17 | 52,131 | Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone on the cardiovascular system of patients with parkinson's disease. | Neurology | 1975 | https://conductscience.org/library/papers/52131 | PubMed |
| 18 | 4,628,192 | [Advances in L-DOPA therapy for parkinsonism through combination with a decarboxylase inhibitor. Results of a long-term study]. | Nervenarzt | 1972 | https://conductscience.org/library/papers/4628192 | PubMed |
| 19 | 4,365,556 | Morphological and biochemical studies on liver biopsies of parkinsonian patients treated with levodopa and decarboxylase inhibitor. | Acta Neurol Scand | 1974 | https://conductscience.org/library/papers/4365556 | PubMed |
| 20 | 5,293,414 | Adverse clinical side effects of levodopa therapy. | Contemp Neurol Ser | 1971 | https://conductscience.org/library/papers/5293414 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24,128,899 | Normal biodistribution pattern and physiologic variants of 18F-DOPA PET imaging. | Nucl Med Commun | 2013 | https://conductscience.org/library/papers/24128899 | PubMed |
| 21,486,284 | Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease. | Br J Pharmacol | 2011 | https://conductscience.org/library/papers/21486284 | PubMed |
| 15,548,480 | Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. | J Neurol Neurosurg Psychiatry | 2004 | https://conductscience.org/library/papers/15548480 | PubMed |
| 8,828,615 | Effect of L-dopa on visual evoked potentials and neuropsychological tests in adult phenylketonuria patients. | Eur J Pediatr | 1996 | https://conductscience.org/library/papers/8828615 | PubMed |
| 8,792,058 | Pharmacokinetic optimisation in the treatment of Parkinson's disease. | Clin Pharmacokinet | 1996 | https://conductscience.org/library/papers/8792058 | PubMed |
| 7,946,003 | A risk-benefit assessment of drugs used in the management of Parkinson's disease. | Drug Saf | 1994 | https://conductscience.org/library/papers/7946003 | PubMed |
| 7,807,950 | Effect of L-dopa on pattern visual evoked potentials (P-100) and neuropsychological tests in untreated adult patients with phenylketonuria. | J Inherit Metab Dis | 1994 | https://conductscience.org/library/papers/7807950 | PubMed |
| 7,049,658 | Fixed combination drug therapy. | Drugs | 1982 | https://conductscience.org/library/papers/7049658 | PubMed |
| 6,617,727 | Intestinal absorption of levodopa in man. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6617727 | PubMed |
| 3,927,334 | The comparative long-term effects of ciladopa (AY-27,110), a chemically novel dopaminergic agonist, in 6-OHDA-lesioned and intact rats. | Psychopharmacology (Berl) | 1985 | https://conductscience.org/library/papers/3927334 | PubMed |
| 2,775,615 | The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa. | Br J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2775615 | PubMed |
| 2,404,503 | The influence of levodopa on gastric emptying in man. | Br J Clin Pharmacol | 1990 | https://conductscience.org/library/papers/2404503 | PubMed |
| 2,119,841 | The effect of benserazide on the peripheral and central distribution and metabolism of levodopa after acute and chronic administration in the rat. | Br J Pharmacol | 1990 | https://conductscience.org/library/papers/2119841 | PubMed |
| 1,761,075 | Effect of age on the pharmacokinetics of oral levodopa in patients with Parkinson's disease. | Eur J Clin Pharmacol | 1991 | https://conductscience.org/library/papers/1761075 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/782834
GET https://conductscience.org/api/papers/v1/782834/references?page=2